Carlsmed is a creator of spine fusion devices on a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Carlsmed is transforming medicine by personalizing complex spine surgery to improve patient outcomes.
Carlsmed was founded in 2018 by Mike Cordonnier and Niall Casey. The company is headquartered in La Jolla, California.
Carlsmed provides a comprehensive Digital Solution for surgeons to inform, engage, and empower patients in the pre-operative decision-making process.
aprevo® devices are personalized to improve the standard of care for the surgical treatment of adults with spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create aprevo® spine fusion devices to align with the surgeon’s goals for each patient.
Carlsmed is backed by B Capital Group, U.S. Venture Partners (USVP), Cove Fund, Wavemaker Three-Sixty Health, The Vertical Group, Device of Tomorrow Capital, and others. The company raised $30M in a Series B round on Apr 19, 2022. This brings Carlsmed's total funding to $42.5M to date.